⌘K

Login Start Free

Home/Filings/4/0001171843-15-000421

4//SEC Filing

Anika Therapeutics, Inc. 4

Accession 0001171843-15-000421

$ANIKCIK 0000898437operating

View on SEC.gov Company Profile

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 5:21 PM ET

Size

7.0 KB

Accession

0001171843-15-000421

Insider Transaction Report

Form 4

Period: 2015-01-26

Anika Therapeutics, Inc.ANIK

Director

Transactions

Exercise/Conversion
Stock Options (Right to Buy)
2015-01-26−1,275→ 0 total
Exercise: $14.33Exp: 2015-04-25→ Common Stock (1,275 underlying)
Award
Common Stock
2015-01-26$14.33/sh+1,275$18,271→ 31,817 total

Footnotes (1)

[F1]Exercise of stock options granted on April 25, 2005 with an expiration date of April 25, 2015.

Documents

1 file

4
gff4_bower012815.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Anika Therapeutics, Inc.

CIK 0000898437

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000898437

Filing Metadata

Form type: 4
Filed: Jan 27, 7:00 PM ET
Accepted: Jan 28, 5:21 PM ET
Size: 7.0 KB

View on SEC.gov